Capital Raising
Equity and debt for technology companies. We know who's writing what cheques across growth equity, private credit, and family offices – and we structure rounds that hold up at term-sheet stage.
Sell-side, buy-side, corporate development. Technology sector.
Sell-side, buy-side, capital raising, corporate development. That's the entire scope – we work this lane only.
Equity and debt for technology companies. We know who's writing what cheques across growth equity, private credit, and family offices – and we structure rounds that hold up at term-sheet stage.
Sell-side mandates, joint ventures, minority exits. We get founders and sponsors out – fully or partially – without losing valuation in the back-and-forth.
Buy-side mandates for sponsors and strategics. Origination, diligence, execution. Tech-fluent enough to read the product and the multiple in the same meeting.
Market entry, partnership structuring, commercial strategy. For technology operators thinking in years, not quarters.
Partner-led delivery – same hands from intro to close.
Former Goldman Sachs IB & AM Associate with a strong track record in capital raising and M&A across the growth-equity and private credit spectrum in Europe.
M&A advisor with a proven track record of structuring complex strategic transactions, cross-border origination, and negotiation across European mid-market.
We've executed deals at Goldman Sachs and Tier-1 hedge funds. The process discipline carries over. The eight-layer approval chain doesn't.
London, Riga, Cyprus. Most of the work runs through London. The other offices exist because some clients and counterparties don't.
Three principles we actually operate by – not the boilerplate kind printed on slides and forgotten.
If the work wouldn't pass our own bar, it doesn't leave the room. We benchmark against the firm we'd hire – not the shop down the street.
The strongest argument wins. Seniority gets a vote, not a veto – and the answer changes when the better idea shows up.
Numbers settle it. If our thesis can't survive the data, we change the thesis – not the data.